Evidence map›Paper›PMID 42320936›Full record

ArticleThe Australian & New Zealand journal of obstetrics & gynaecology2026

Retrospective Cohort Study of Foetal Growth Restricted Births After 40 Weeks at an Australian Tertiary Maternity Hospital Between 2018 and 2021.

Charmi Nadeema Perera, Amy Goh

Abstract read
In one paragraph

Article in The Australian & New Zealand journal of obstetrics & gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Charmi Nadeema PereraDepartment of Obstetrics and Gynaecology, Western Sydney Local Health District, Westmead, New South Wales, Australia.ORCID https://orcid.org/0000-0003-0453-0781
Amy GohDepartment of Obstetrics and Gynaecology, Western Sydney Local Health District, Westmead, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFoetal growth restriction (FGR) increases risks of neonatal morbidity and mortality. Identifying and preventing FGR is key to improving neonatal outcomes. FGR risk assessment tools are designed to recognise women at high risk of FGR.

aimsThis study aims to compare the theoretical effectiveness of four different FGR risk factor assessment pathways in identifying women at risk for FGR: New South Wales (NSW) Foetal Safety Risk Assessment, Safer Baby Bundle FGR pathway, NHS Saving Babies' Lives risk assessment tool and RCOG Screening for Small Gestational Age foetus pathway. These pathways recommend management plans for women identified to be at risk for FGR. MATERIALS AND

methodsThis retrospective study at Westmead Hospital compared singleton births between 2018 and 2021 that were ≥ 40 weeks' gestation with birthweight < 3rd percentile, against the four FGR pathways. Prior to 2022, NSW had no recommended algorithm to identify patients at risk for FGR.

results116 women and 116 growth-restricted babies were included for analysis. The NSW Foetal Safety Risk Assessment would have identified 32 (27.6%) women to be at risk for FGR, the Safer Baby Bundle 39 (33.6%), the NHS tool 44 (37.9%) and the RCOG pathway 36 (30%). 32 (23%) babies required neonatal intensive care or special care nursery admission with no neonatal deaths or stillbirths.

conclusionFoetal risk assessment tools increase identification of women at risk of FGR, although none are perfect. Ongoing improvements to risk assessment algorithms will help identify larger cohorts of patients at risk of FGR and reduce poor neonatal outcomes.

Indexed as

Fetal Growth RetardationAdultFemaleGestational AgeHospitals, MaternityHumansInfant, NewbornNew South WalesPregnancyRetrospective StudiesRisk AssessmentRisk FactorsTertiary Care Centersfoetal growth restrictionlow birth weightnewbornrisk assessment

Identifiers

PMID42320936
PMCPMC13282158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.